Form 8-K - Current report:
SEC Accession No. 0001104659-25-076837
Filing Date
2025-08-12
Accepted
2025-08-12 16:11:52
Documents
38
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523183d1_8k.htm   iXBRL 8-K 25281
2 EXHIBIT 99.1 tm2523183d1_ex99-1.htm EX-99.1 151880
3 EXHIBIT 99.2 tm2523183d1_ex99-2.htm EX-99.2 39423
7 GRAPHIC tm2523183d1_ex99-1img001.jpg GRAPHIC 7204
8 GRAPHIC tm2523183d1_ex99-2img001.jpg GRAPHIC 193958
9 GRAPHIC tm2523183d1_ex99-2img002.jpg GRAPHIC 389471
10 GRAPHIC tm2523183d1_ex99-2img003.jpg GRAPHIC 110073
11 GRAPHIC tm2523183d1_ex99-2img004.jpg GRAPHIC 214657
12 GRAPHIC tm2523183d1_ex99-2img005.jpg GRAPHIC 95341
13 GRAPHIC tm2523183d1_ex99-2img006.jpg GRAPHIC 143082
14 GRAPHIC tm2523183d1_ex99-2img007.jpg GRAPHIC 204567
15 GRAPHIC tm2523183d1_ex99-2img008.jpg GRAPHIC 113913
16 GRAPHIC tm2523183d1_ex99-2img009.jpg GRAPHIC 180644
17 GRAPHIC tm2523183d1_ex99-2img010.jpg GRAPHIC 140881
18 GRAPHIC tm2523183d1_ex99-2img011.jpg GRAPHIC 131204
19 GRAPHIC tm2523183d1_ex99-2img012.jpg GRAPHIC 227400
20 GRAPHIC tm2523183d1_ex99-2img013.jpg GRAPHIC 99666
21 GRAPHIC tm2523183d1_ex99-2img014.jpg GRAPHIC 166430
22 GRAPHIC tm2523183d1_ex99-2img015.jpg GRAPHIC 55919
23 GRAPHIC tm2523183d1_ex99-2img016.jpg GRAPHIC 187150
24 GRAPHIC tm2523183d1_ex99-2img017.jpg GRAPHIC 137580
25 GRAPHIC tm2523183d1_ex99-2img018.jpg GRAPHIC 162549
26 GRAPHIC tm2523183d1_ex99-2img019.jpg GRAPHIC 165753
27 GRAPHIC tm2523183d1_ex99-2img020.jpg GRAPHIC 224374
28 GRAPHIC tm2523183d1_ex99-2img021.jpg GRAPHIC 150531
29 GRAPHIC tm2523183d1_ex99-2img022.jpg GRAPHIC 273138
30 GRAPHIC tm2523183d1_ex99-2img023.jpg GRAPHIC 127065
  Complete submission text file 0001104659-25-076837.txt   5794876

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20250812.xsd EX-101.SCH 3020
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20250812_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20250812_pre.xml EX-101.PRE 22362
40 EXTRACTED XBRL INSTANCE DOCUMENT tm2523183d1_8k_htm.xml XML 3704
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 251206817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)